Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Precision Biosciences (DTIL) Loans and Notes Receivables (2023 - 2024)

Precision Biosciences (DTIL) has disclosed Loans and Notes Receivables for 2 consecutive years, with $12.3 million as the latest value for Q2 2024.

  • On a quarterly basis, Loans and Notes Receivables changed N/A to $12.3 million in Q2 2024 year-over-year; TTM through Jun 2024 was $12.3 million, a N/A change, with the full-year FY2023 number at $11.9 million, changed N/A from a year prior.
  • Loans and Notes Receivables was $12.3 million for Q2 2024 at Precision Biosciences, up from $11.6 million in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $12.3 million in Q2 2024 to a low of $11.6 million in Q1 2024.